Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.00 (+0.32%)
As of: Oct 1, 2026 · 10:00 AM EDT

Vistagen Therapeutics (VTGN) Shares Outstanding (Entity) (2012 - 2026)

Updated

Vistagen Therapeutics' Shares Outstanding (Entity) was 44.38 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 44.6% from 30.68 million a year earlier and up 8.2% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Shares Outstanding (Entity) at Vistagen Therapeutics came in at 41.03 million, up 40.7% from FY2025.

  • Shares Outstanding (Entity) has now increased for four consecutive fiscal years, though with a five-year compound annual growth rate of -13.8% (FY2021 to FY2026).
  • In earlier fiscal years, Shares Outstanding (Entity) was 29.16 million in FY2025 (+50.7%), 19.35 million in FY2024 (+145.9%), 7.87 million in FY2023 (+14.3%) and 6.89 million in FY2022 (-92.0%).
  • The fiscal Q1 2027 figure marks the highest quarterly Shares Outstanding (Entity) since fiscal Q4 2021.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 17 straight quarters, with growth averaging 51.6% over the last eight quarters.
  • The best year-over-year quarter for Shares Outstanding (Entity) over five years was fiscal Q3 2024 (growth of 291.6%); the worst was fiscal Q4 2022 (a decline of 92.0%).
  • Per Business Quant data, VTGN's Shares Outstanding (Entity) in the three fiscal quarters before Q1 2027 was 41.03 million (Q4 2026), 39.62 million (Q3 2026) and 39.5 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - 44.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.38 Mn
Mar 31, 2026 41.03 Mn
Dec 31, 2025 39.62 Mn
Sep 30, 2025 39.50 Mn
Jun 30, 2025 30.68 Mn
Mar 31, 2025 29.16 Mn
Dec 31, 2024 28.86 Mn
Sep 30, 2024 27.84 Mn
Jun 30, 2024 27.06 Mn
Mar 31, 2024 19.35 Mn
Dec 31, 2023 27.03 Mn
Sep 30, 2023 10.04 Mn
Jun 30, 2023 7.38 Mn
Mar 31, 2023 7.87 Mn
Dec 31, 2022 6.90 Mn
Sep 30, 2022 6.90 Mn
Jun 30, 2022 6.90 Mn
Mar 31, 2022 6.89 Mn
Dec 31, 2021 6.74 Mn
Sep 30, 2021 6.44 Mn
API Access

Vistagen Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=VTGN&period=max&api_key=YOUR_API_KEY